Ginkgo Bioworks DNA Consumer and technology — Concentration risk
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's consumer and technology — concentration risk.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's consumer and technology — concentration risk?
- Ginkgo Bioworks (DNA) reported consumer and technology — concentration risk of 0% in Q1 2026.
- How has Ginkgo Bioworks's consumer and technology — concentration risk changed year-over-year?
- Ginkgo Bioworks's consumer and technology — concentration risk decreased by 100.0% year-over-year, from 1% to 0%.
- What does consumer and technology — concentration risk mean?
- This metric measures the proportion of revenue derived from a single customer or a small group of customers within the consumer and technology segment. A high concentration indicates significant dependency on key accounts, which poses a risk to revenue stability if those relationships are terminated or scaled back. Monitoring this percentage helps investors assess the diversification of the segment's client base and the potential impact of client-specific volatility on overall financial performance.